Two Sigma Securities’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Two Sigma Securities’s Portfolio VYNT Stock Details VYNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,307	Closed	-$12K	–	3458
2022 Q3	$12K	Buy	+4,307	New	+$16.3K	﹤0.01%	2384
2019 Q4	–	Sell	-248	Closed	-$4K	–	2727
2019 Q3	$4K	Sell	248 -34	-12%	-$662	﹤0.01%	2012
2019 Q2	$7K	Buy	+282	New	+$8.8K	﹤0.01%	2015
2019 Q1	–	Sell	-128	Closed	-$5K	–	2583
2018 Q4	$5K	Sell	128 -28	-18%	-$2.36K	﹤0.01%	2059
2018 Q3	$24K	Buy	+156	New	+$23.1K	﹤0.01%	2421
2018 Q1	–	Sell	-451	Closed	-$125K	–	3039
2017 Q4	$125K	Buy	451 +354	+365%	+$135K	﹤0.01%	1425
2017 Q3	$39K	Buy	+97	New	+$50.6K	﹤0.01%	766
2017 Q2	–	Sell	-107	Closed	-$66K	–	1243
2017 Q1	$66K	Buy	+107	New	+$38.1K	0.01%	781

Other funds holding VYNT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Two Sigma Securities's VYNT Position: Q4 2022 in Review

Two Sigma Securities sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2022, closing a stake of 4,307 shares — an estimated $12K sold.

Two Sigma Securities first reported a position in VYNT in Q1 2017 and held it in 8 quarters. The position peaked at $125K in Q4 2017. 17 funds tracked by Wall St. Rank hold VYNT as of Q4 2022.

Two Sigma Securities reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Two Sigma Securities sold 4,307 Vyant Bio, Inc. Common Stock shares in Q4 2022, an estimated $12K.
Two Sigma Securities first reported a position in Vyant Bio, Inc. Common Stock in Q1 2017 and held it in 8 quarters.
Two Sigma Securities's Vyant Bio, Inc. Common Stock position peaked at $125K in Q4 2017.
17 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.